ipratropium bromide/salbutamol neutec 0.5/2.5 mg per 2.5 ml nebuliser solution
neutec inhaler ireland limited - ipratropium bromide monohydrate; salbutamol sulfate - nebuliser solution - salbutamol and ipratropium bromide
salbutamol an salbutamol (as sulfate) 5mg/2.5ml inhalation ampoules
amneal pharma australia pty ltd - salbutamol sulfate -
salbutamol an salbutamol (as sulfate) 2.5mg/2.5ml inhalation ampoules
amneal pharma australia pty ltd - salbutamol sulfate -
ipratropium bromide and albuterol sulfate solution
preferred pharmaceuticals, inc. - ipratropium bromide (unii: j697uz2a9j) (ipratropium - unii:gr88g0i6ul), albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - ipratropium bromide anhydrous 0.5 mg in 3 ml - ipratropium bromide and albuterol sulfate inhalation solution is indicated for the treatment of bronchospasm associated with copd in patients requiring more than one bronchodilator. ipratropium bromide and albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components, or to atropine and its derivatives.
ipratropium bromide and albuterol sulfate solution
proficient rx lp - ipratropium bromide (unii: j697uz2a9j) (ipratropium - unii:gr88g0i6ul), albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - ipratropium bromide anhydrous 0.5 mg in 3 ml - ipratropium bromide and albuterol sulfate inhalation solution is indicated for the treatment of bronchospasm associated with copd in patients requiring more than one bronchodilator. ipratropium bromide and albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components, or to atropine and its derivatives.
salbutamol sandoz salbutamol 5mg/2.5ml (as sulfate) inhalation ampoules
sandoz pty ltd - salbutamol sulfate -
salbutamol cipla salbutamol 5mg/2.5ml (as sulfate) inhalation ampoules
cipla australia pty ltd - salbutamol sulfate, quantity: 6 mg (equivalent: salbutamol, qty 5 mg) - inhalation, conventional - excipient ingredients: sulfuric acid; water for injections; sodium chloride - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise induced asthma or in other situations known to induce bronchospasm.
salbutamol cipla salbutamol 2.5mg/2.5ml (as sulfate) inhalation ampoules
cipla australia pty ltd - salbutamol sulfate, quantity: 3 mg (equivalent: salbutamol, qty 2.5 mg) - inhalation, conventional - excipient ingredients: water for injections; sulfuric acid; sodium chloride - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise induced asthma or in other situations known to induce bronchospasm.
ipratropium bromide and albuterol sulfate- ipratropium bromide and albuterol sulfate solution
eon labs, inc. - ipratropium bromide (unii: j697uz2a9j) (ipratropium - unii:gr88g0i6ul), albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - ipratropium bromide 0.5 mg in 3 ml - ipratropium bromide and albuterol sulfate is indicated for the treatment of bronchospasm associated with copd in patients requiring more than one bronchodilator. ipratropium bromide and albuterol sulfate is contraindicated in patients with a history of hypersensitivity to any of its components, or to atropine and its derivatives.
salbutamol sandoz salbutamol 2.5mg/2.5ml (as sulfate) inhalation ampoules
sandoz pty ltd - salbutamol sulfate -